Lois NaYeon Yoo

Cooley advised Thesis Care on its $45 million Series A funding led by Oak HC/FT. Robert Warshaw led the Cooley team advising Thesis Care, an artificial intelligence-powered care team platform for scalable clinical capacity.

Cooley advised CHARM Therapeutics, a biotechnology company pioneering the next generation of precision oncology treatments through its proprietary artificial intelligence-driven drug discovery platform, on its $80 million Series B financing, to advance its next-generation menin inhibitor into clinical development.

Cooley advised Hadean Ventures and M Ventures as co-lead investors, alongside several other investors, in Actithera’s oversubscribed $75.5 million Series A financing. Partner Ryan Sansom led the Cooley team that advised the syndicate of investors, including Hadean Ventures, M Ventures, Bioqube Ventures, 4BIO Ventures and Sofinnova Partners.

Cooley advised MongoDB (Nasdaq: MDB), a leading database for modern applications, on its acquisition of Voyage AI, a pioneer in state-of-the-art embedding and reranking models that power next-generation artificial intelligence applications.

Cooley advised Everbridge, a global leader in critical event management and national public warning solutions, on its definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valuing Everbridge at approximately $1.8 billion.